Glycopyrrolate Dosing for a 22kg Child
For a 22kg child, the recommended dose of glycopyrrolate injection is 0.004 mg/kg, which equals 0.088 mg per dose. This dose can be administered intravenously or intramuscularly based on the clinical indication 1, 2.
Dosing Based on Clinical Indication
Preanesthetic Medication
- Dose: 0.004 mg/kg IM (0.088 mg for a 22kg child)
- Timing: 30-60 minutes prior to anesthesia induction or when preanesthetic medications are administered
- Maximum: Not to exceed 0.1 mg in a single dose 1
Intraoperative Use
- Dose: 0.004 mg/kg IV (0.088 mg for a 22kg child)
- Maximum: Not to exceed 0.1 mg in a single dose
- Frequency: May be repeated at intervals of 2-3 minutes as needed
- Note: If glycopyrrolate was used as preanesthetic medication, additional intraoperative doses are rarely needed 1, 2
Reversal of Neuromuscular Blockade
- Dose: 0.2 mg for each 1.0 mg of neostigmine or 5.0 mg of pyridostigmine
- Administration: Can be mixed in the same syringe with neostigmine or pyridostigmine and administered simultaneously by IV injection 1
Important Considerations
Weight-Based Dosing Precautions
- For children weighing less than 25kg (like this 22kg child), the standard pediatric dosing of 0.004 mg/kg is appropriate 3
- The total dose should not exceed 0.1 mg in a single administration 1
Administration Routes
- Can be administered intramuscularly or intravenously without dilution
- Compatible with dextrose 5% and 10% in water, saline, dextrose 5% in sodium chloride 0.45%, sodium chloride 0.9%, and Ringer's Injection 1
- Incompatible with Lactated Ringer's solution 1
Monitoring
- Monitor for anticholinergic side effects including dry mouth, constipation, urinary retention, flushing, and tachycardia
- Be particularly vigilant in younger children who may be more sensitive to anticholinergic effects 4
Special Situations
For Chronic Drooling
If glycopyrrolate is being used for chronic drooling in this child:
- Starting dose: 0.02 mg/kg three times daily (0.44 mg TID for a 22kg child)
- Titration: Can be increased in increments of 0.02 mg/kg every 5-7 days
- Maximum dose: 0.1 mg/kg three times daily, not exceeding 3 mg per dose 5
- Note: While FDA approval for drooling is for children 3-16 years, studies have shown efficacy in younger children as well 6
Overdose Management
If overdose occurs:
- For peripheral anticholinergic effects: neostigmine methylsulfate may be given IV in proportionately smaller doses than the adult dose of 0.25 mg
- For CNS symptoms: physostigmine may be used in proportionately smaller doses than the adult dose of 0.5-2 mg 1
Practical Administration Tips
- Visually inspect solution for particulate matter and discoloration before administration
- Do not combine glycopyrrolate with medications that would result in a pH higher than 6.0 1
- Calculate the exact dose carefully based on accurate weight measurement to avoid dosing errors
Remember that glycopyrrolate has a long duration of action, so additional doses for anticholinergic effect are rarely needed if it was used as preanesthetic medication 1, 2.